Literature DB >> 10902770

A two-stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon.

E Susol1, A J MacGregor, J H Barrett, H Wilson, C Black, K Welsh, A Silman, B Ollier, J Worthington.   

Abstract

OBJECTIVE: To identify chromosomal regions containing genes involved in the susceptibility to primary Raynaud's phenomenon (RP).
METHODS: Six extended families with multiple individuals affected with primary RP (n = 37) were examined for linkage in a 2-stage, whole-genome screen, using a total of 298 microsatellite markers.
RESULTS: Multipoint, nonparametric linkage analysis identified 5 areas of possible linkage, with a nominal level of significance of P < or = 0.05. Analysis of a finer map of markers in these regions defined the regions of linkage as 21.4 cM on 6q13-6q23.3 (D6S261; P = 0.0004), 10.2 cM on 7p22-7p15 (D7S664; P = 0.014), 1.6 cM on 9p23-9p22 (D9S156; P = 0.0075), 5.1 cM on 17p13.1-17p12 (D17S1791; P = 0.036), and 11.8 cM on Xp11.4-Xp11.23 (DXS8054; P = 0.006). Three potential candidate genes map to these regions: the beta subunit of the muscle acetylcholine receptor and the serotonin 1B and 1E receptors.
CONCLUSION: These results provide evidence of the presence and location of genes that are involved in the genetic susceptibility to primary RP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902770     DOI: 10.1002/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Genomewide scans of complex human diseases: true linkage is hard to find.

Authors:  J Altmüller; L J Palmer; G Fischer; H Scherb; M Wjst
Journal:  Am J Hum Genet       Date:  2001-09-14       Impact factor: 11.025

Review 3.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

4.  Glutathione S-transferase M1 and GST T1 genetic polymorphisms and Raynaud's phenomenon in French vinyl chloride monomer-exposed workers.

Authors:  Luc Fontana; Marie-Jeanne Marion; Sylvie Ughetto; Pierre Catilina
Journal:  J Hum Genet       Date:  2006-09-15       Impact factor: 3.172

Review 5.  [Functional vascular acrosyndromes].

Authors:  Peter Klein-Weigel; Andreas Ruttloff; Dana König; Jessica Nielitz; Julia Steindl; Oliver Sander; Jutta G Richter
Journal:  Inn Med (Heidelb)       Date:  2022-05-16

Review 6.  International consensus criteria for the diagnosis of Raynaud's phenomenon.

Authors:  Emanual Maverakis; Forum Patel; Daniel G Kronenberg; Lorinda Chung; David Fiorentino; Yannick Allanore; Serena Guiducci; Roger Hesselstrand; Laura K Hummers; Chris Duong; Bashar Kahaleh; Alexander Macgregor; Marco Matucci-Cerinic; Frank A Wollheim; Maureen D Mayes; M Eric Gershwin
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

7.  Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

Authors:  Zsuzsanna H McMahan; Fredrick M Wigley
Journal:  Int J Clin Rheumtol       Date:  2010

Review 8.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

9.  Treatment of Raynaud's phenomenon: new insights and developments.

Authors:  Ariane L Herrick
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

10.  A common genetic factor underlies hypertension and other cardiovascular disorders.

Authors:  Frances M K Williams; Lynn F Cherkas; Tim D Spector; Alex J MacGregor
Journal:  BMC Cardiovasc Disord       Date:  2004-11-01       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.